Enrolling
Redefine 3 (4942)
Redefine 3 (4942)
Overview: This is a study to observe the effects of CagriSema on heart disease in people living with obesity, and diseases of the heart and blood vessels.
Type 2 Diabetes
Enrolling
Afrezza (INHALE-1)
Afrezza (INHALE-1)
Overview: This study evaluates the safety and effectiveness of an inhaled short-acting insulin in children.
Enrolling
Eversense CGM (0039)
Eversense CGM (0039)
Overview: This is a study that will test the Eversense continuous glucose monitoring compared to a blood glucose meter in patients that are not on or ever tried a CGM.
Closed
Medtronic Guardian Connect System with In Pen and Smart Devices
Medtronic Guardian Connect System with In Pen and Smart Devices
Overview: This is a study of the Guardian Connect system which is a real-time continuous glucose monitoring system known as a CGM. The participants will use smart insulin pens or insulin pens with smart caps for all of their daily injections.
Closed
Once-weekly Basal Insulin Therapy (BDCV)
Once-weekly Basal Insulin Therapy (BDCV)
Overview: The purpose of this study is to compare the results of a weekly insulin with a daily insulin for type 2 diabetes.
Can’t find a study that works for you?
Subscribe for Information on Other Studies
Fill out the form below an we will let you know when a study becomes available that you may be interested in:
